Alpha 2.0
Login Register
» Articles » PMID: 1749381

Discovery of Antitoxins and Development of Antibody Preparations for Clinical Uses from 1890 to 1990

Overview
Journal Mol Immunol
Specialties Allergy & Immunology
Molecular Biology
Date 1991 Dec 1
PMID 1749381
Citations 5
Authors
P Gronski
F R Seiler
H G Schwick
Affiliations
Soon will be listed here.
Citing Articles

Safety and efficacy of a purified canine immunoglobulin G formulation for treatment of 76 cats clinically affected by the Australian paralysis tick (Ixodes holocyclus).

Padula A Aust Vet J. 2022; 100(10):476-478.

PMID: 35788553 PMC: 9795890. DOI: 10.1111/avj.13194.

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.

Tharmalingam T, Han X, Wozniak A, Saward L Hum Vaccin Immunother. 2021; 18(2):1886560.

PMID: 34010089 PMC: 9090292. DOI: 10.1080/21645515.2021.1886560.

Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients.

Schroeder Jr H, Dougherty C Infection. 2012; 40(6):601-11.

PMID: 22968971 PMC: 3501191. DOI: 10.1007/s15010-012-0323-9.

Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Gutierrez J, Leon G, Lomonte B Clin Pharmacokinet. 2003; 42(8):721-41.

PMID: 12846594 DOI: 10.2165/00003088-200342080-00002.

Discovery of antibodies.

Llewelyn M, Hawkins R, Russell S BMJ. 1992; 305(6864):1269-72.

PMID: 1477573 PMC: 1883762. DOI: 10.1136/bmj.305.6864.1269.